186 related articles for article (PubMed ID: 25962764)
1. Menopausal hormone therapy and mortality among endometrial cancer patients in the NIH-AARP Diet and Health Study.
Felix AS; Arem H; Trabert B; Gierach GL; Park Y; Pfeiffer RM; Brinton LA
Cancer Causes Control; 2015 Aug; 26(8):1055-63. PubMed ID: 25962764
[TBL] [Abstract][Full Text] [Related]
2. Use of postmenopausal hormone therapies and risk of histology- and hormone receptor-defined breast cancer: results from a 15-year prospective analysis of NIH-AARP cohort.
Wang SM; Pfeiffer RM; Gierach GL; Falk RT
Breast Cancer Res; 2020 Nov; 22(1):129. PubMed ID: 33239054
[TBL] [Abstract][Full Text] [Related]
3. Unopposed estrogen and estrogen plus progestin menopausal hormone therapy and lung cancer risk in the NIH-AARP Diet and Health Study Cohort.
Brinton LA; Schwartz L; Spitz MR; Park Y; Hollenbeck AR; Gierach GL
Cancer Causes Control; 2012 Mar; 23(3):487-96. PubMed ID: 22367699
[TBL] [Abstract][Full Text] [Related]
4. Endometrial cancer and menopausal hormone therapy in the National Institutes of Health-AARP Diet and Health Study cohort.
Lacey JV; Leitzmann MF; Chang SC; Mouw T; Hollenbeck AR; Schatzkin A; Brinton LA
Cancer; 2007 Apr; 109(7):1303-11. PubMed ID: 17315161
[TBL] [Abstract][Full Text] [Related]
5. Menopausal hormone therapy and mortality among women diagnosed with ovarian cancer in the NIH-AARP Diet and Health Study.
Felix AS; Bunch K; Yang HP; Arem H; Trabert B; Gierach GL; Park Y; Lowery WJ; Brinton LA
Gynecol Oncol Rep; 2015 Aug; 13():13-7. PubMed ID: 26425711
[TBL] [Abstract][Full Text] [Related]
6. Reproductive factors and menopausal hormone therapy and bladder cancer risk in the NIH-AARP Diet and Health Study.
Daugherty SE; Lacey JV; Pfeiffer RM; Park Y; Hoover RN; Silverman DT
Int J Cancer; 2013 Jul; 133(2):462-72. PubMed ID: 23319449
[TBL] [Abstract][Full Text] [Related]
7. Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort.
Lacey JV; Brinton LA; Leitzmann MF; Mouw T; Hollenbeck A; Schatzkin A; Hartge P
J Natl Cancer Inst; 2006 Oct; 98(19):1397-405. PubMed ID: 17018786
[TBL] [Abstract][Full Text] [Related]
8. Is breast cancer risk the same for all progestogens?
Stute P
Arch Gynecol Obstet; 2014 Aug; 290(2):207-9. PubMed ID: 24838289
[TBL] [Abstract][Full Text] [Related]
9. Menopausal hormone therapy and cancer risk: An overestimated risk?
Simin J; Tamimi R; Lagergren J; Adami HO; Brusselaers N
Eur J Cancer; 2017 Oct; 84():60-68. PubMed ID: 28783542
[TBL] [Abstract][Full Text] [Related]
10. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women.
Lacey JV; Brinton LA; Lubin JH; Sherman ME; Schatzkin A; Schairer C
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1724-31. PubMed ID: 16030108
[TBL] [Abstract][Full Text] [Related]
11. Body mass index, physical activity, and television time in relation to mortality risk among endometrial cancer survivors in the NIH-AARP Diet and Health Study cohort.
Arem H; Pfeiffer RM; Moore SC; Brinton LA; Matthews CE
Cancer Causes Control; 2016 Nov; 27(11):1403-1409. PubMed ID: 27730319
[TBL] [Abstract][Full Text] [Related]
12. Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk?
Trabert B; Wentzensen N; Yang HP; Sherman ME; Hollenbeck AR; Park Y; Brinton LA
Int J Cancer; 2013 Jan; 132(2):417-26. PubMed ID: 22553145
[TBL] [Abstract][Full Text] [Related]
13. Menopausal hormone therapy and risk of epithelial ovarian cancer.
Rossing MA; Cushing-Haugen KL; Wicklund KG; Doherty JA; Weiss NS
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2548-56. PubMed ID: 18086757
[TBL] [Abstract][Full Text] [Related]
14. Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP diet and health study.
Chang SC; Lacey JV; Brinton LA; Hartge P; Adams K; Mouw T; Carroll L; Hollenbeck A; Schatzkin A; Leitzmann MF
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):723-30. PubMed ID: 17416763
[TBL] [Abstract][Full Text] [Related]
15. Menopausal hormone therapy and breast cancer risk in the NIH-AARP Diet and Health Study Cohort.
Brinton LA; Richesson D; Leitzmann MF; Gierach GL; Schatzkin A; Mouw T; Hollenbeck AR; Lacey JV
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3150-60. PubMed ID: 18990757
[TBL] [Abstract][Full Text] [Related]
16. Prediagnosis body mass index, physical activity, and mortality in endometrial cancer patients.
Arem H; Park Y; Pelser C; Ballard-Barbash R; Irwin ML; Hollenbeck A; Gierach GL; Brinton LA; Pfeiffer RM; Matthews CE
J Natl Cancer Inst; 2013 Mar; 105(5):342-9. PubMed ID: 23297041
[TBL] [Abstract][Full Text] [Related]
17. Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies.
Pfeiffer RM; Park Y; Kreimer AR; Lacey JV; Pee D; Greenlee RT; Buys SS; Hollenbeck A; Rosner B; Gail MH; Hartge P
PLoS Med; 2013; 10(7):e1001492. PubMed ID: 23935463
[TBL] [Abstract][Full Text] [Related]
18. Prediagnostic use of estrogen-only therapy is associated with improved colorectal cancer survival in menopausal women: a Swedish population-based cohort study.
Simin J; Liu Q; Wang X; Fall K; Williams C; Callens S; Engstrand L; Brusselaers N
Acta Oncol; 2021 Jul; 60(7):881-887. PubMed ID: 33861686
[TBL] [Abstract][Full Text] [Related]
19. Ovarian cancer and menopausal hormone therapy in the NIH-AARP diet and health study.
Trabert B; Wentzensen N; Yang HP; Sherman ME; Hollenbeck A; Danforth KN; Park Y; Brinton LA
Br J Cancer; 2012 Sep; 107(7):1181-7. PubMed ID: 22929888
[TBL] [Abstract][Full Text] [Related]
20. Menopausal hormone therapy use and long-term all-cause and cause-specific mortality in the Long Island Breast Cancer Study Project.
Wang T; Bradshaw PT; Moorman PG; Nyante SJ; Nichols HB; Shantakumar S; Parada H; Khankari NK; Terry MB; Teitelbaum SL; Neugut AI; Gammon MD
Int J Cancer; 2020 Dec; 147(12):3404-3415. PubMed ID: 32588422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
